Molecular diversity of HIV in Albania

被引:25
作者
Ciccozzi, M
Gori, C
Boros, S
Ruiz-Alvarez, MJ
Harxhi, A
Dervishi, M
Qyra, S
Schinaia, N
D'Arrigo, R
Ceccherini-Silberstein, F
Bino, S
Perno, CF
Rezza, G
机构
[1] Ist Super Sanita, Dept Infect Dis, Epidemiol Unit, I-00161 Rome, Italy
[2] Univ Roma Tor Vergata, Dept Expt Med, Rome, Italy
[3] Infect Dis Hosp, Mother Theresa Med Ctr, Tirana, Albania
关键词
D O I
10.1086/431599
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Little information is available on circulating human immunodeficiency virus (HIV) subtypes and resistance to antiretroviral drugs in Albania. To fill this gap, we studied 72 plasma samples from HIV-infected individuals from throughout the country. Subtype classification and genotypic resistance analysis were performed on the HIV pol gene region. The analysis was successfully performed on 66 (91.6%) plasma samples and showed that 43 (65.2%) strains were non-B subtypes (mostly subtype A, as determined by analysis of pol gene sequences). No major mutations in the protease gene were found, whereas analysis of the reverse transcriptase gene revealed a few major mutations associated with resistance. In conclusion, non-B subtypes are predominant in Albania, and the prevalence of resistance to antiretroviral drugs is still low.
引用
收藏
页码:475 / 479
页数:5
相关论文
共 15 条
[1]  
Balotta C, 2001, J ACQ IMMUN DEF SYND, V27, P499, DOI 10.1097/00126334-200108150-00012
[2]   A sudden epidemic of HIV type 1 among injecting drug users in the former Soviet Union:: Identification of subtype A, subtype B, and novel gagA/envB recombinants [J].
Bobkov, A ;
Kazennova, E ;
Selimova, L ;
Bobkova, M ;
Khanina, T ;
Ladnaya, N ;
Kravchenko, A ;
Pokrovsky, V ;
Cheingsong-Popov, R ;
Weber, J .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (08) :669-676
[3]  
*EUR CTR EPID MON, 2003, HIV SURV EUR MID YEA
[4]  
Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
[5]   HIV in central and eastern Europe [J].
Hamers, FF ;
Downs, AM .
LANCET, 2003, 361 (9362) :1035-1044
[6]  
HARXHI A, 2002, RAPID ASSESSMENT RES
[7]  
Johnson Victoria A, 2003, Top HIV Med, V11, P215
[8]  
Jukes TH, 1969, MAMMALIAN PROTEIN ME, P21, DOI [DOI 10.1016/B978-1-4832-3211-9.50009-7, DOI 10.1093/BIOINFORMATICS/BTM404]
[9]   Genotypic characterization of human immunodeficiency virus type 1 in Greece [J].
Nasioulas, G ;
Paraskevis, D ;
Paparizos, V ;
Lazanas, M ;
Karafoulidou, A ;
Hatzakis, A .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (08) :685-690
[10]   Low prevalence of primary mutations associated with drug resistance in antiviral-naive patients at therapy initiation [J].
Perno, CF ;
Cozzi-Lepri, A ;
Balotta, C ;
Bertoli, A ;
Violin, M ;
Monno, L ;
Zauli, T ;
Montroni, M ;
Ippolito, G ;
d'Arminio-Monforte, A .
AIDS, 2002, 16 (04) :619-624